Is Magnetic Resonance Imaging-targeted Biopsy Now the Standard of Care?

被引：3
|
作者：
Pokorny, Morgan R. [1 ]
Thompson, Leslie C. [2 ]
机构：
[1] Auckland City Hosp, Dept Urol, Pk Rd, Auckland 1023, New Zealand
[2] Wesley Hosp, Brisbane, Qld, Australia
来源：
EUROPEAN UROLOGY | 2019年 / 76卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2019.06.002
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / 305
页数：2
相关论文
共 50 条
  • [41] Evaluation of Magnetic Resonance Imaging and Targeted Biopsy: The Difficulty of Finding the Right Reference Standard
    Berg, Sebastian
    Fletcher, Sean A.
    Cole, Alexander P.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (06) : 1299 - 1300
  • [42] Prostate magnetic resonance imaging-targeted biopsy global grade correlates better than highest grade with prostatectomy grade
    Ren, Joyce
    Melamed, Jonathan
    Taneja, Samir S. S.
    Wysock, James S. S.
    Huang, William C. C.
    Lepor, Herbert
    Deng, Fang-Ming
    PROSTATE, 2023, 83 (04): : 323 - 330
  • [43] Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling
    Jean-Paul Noujeim
    Yassir Belahsen
    Yolene Lefebvre
    Marc Lemort
    Maxime Deforche
    Nicolas Sirtaine
    Robin Martin
    Thierry Roumeguère
    Alexandre Peltier
    Romain Diamand
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 575 - 580
  • [44] Magnetic Resonance Imaging-targeted Prostate Biopsies: Is the Right Technique the Right Question?
    Cooperberg, Matthew R.
    EUROPEAN UROLOGY, 2017, 71 (04) : 532 - 533
  • [45] Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling
    Noujeim, Jean-Paul
    Belahsen, Yassir
    Lefebvre, Yolene
    Lemort, Marc
    Deforche, Maxime
    Sirtaine, Nicolas
    Martin, Robin
    Roumeguere, Thierry
    Peltier, Alexandre
    Diamand, Romain
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (03) : 575 - 580
  • [46] Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging-targeted Prostate Biopsy: Optimizing the Number of Cores Taken
    Zattoni, Fabio
    Fasulo, Vittorio
    Kasivisvanathan, Veeru
    Kesch, Claudia
    Marra, Giancarlo
    Martini, Alberto
    Falagario, Ugo
    Soeterik, Timo
    Bergh, Roderick van den
    Rajwa, Pawel
    Gandaglia, Giorgio
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 66 : 16 - 25
  • [47] Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans
    Alberts, Arnout R.
    Schoots, Ivo G.
    Bokhorst, Leonard P.
    van Leenders, Geert J.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2016, 69 (06) : 1129 - 1134
  • [48] Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location
    Robin Martin
    Yassir Belahsen
    Jean-Paul Noujeim
    Yolene Lefebvre
    Marc Lemort
    Maxime Deforche
    Nicolas Sirtaine
    Thierry Roumeguere
    Simone Albisinni
    Alexandre Peltier
    Romain Diamand
    World Journal of Urology, 2023, 41 : 1519 - 1525
  • [49] Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer EDITORIAL COMMENT
    Morash, Chris
    JOURNAL OF UROLOGY, 2021, 205 (05): : 1358 - 1359
  • [50] Reducing or Increasing Overtreatment? How Do We Measure the Impact of Magnetic Resonance Imaging-targeted Biopsy on Prostate Cancer Mortality?
    Taneja, Samir S.
    EUROPEAN UROLOGY, 2024, 86 (03) : 238 - 239
12345